JP2013520167A5 - - Google Patents

Download PDF

Info

Publication number
JP2013520167A5
JP2013520167A5 JP2012553903A JP2012553903A JP2013520167A5 JP 2013520167 A5 JP2013520167 A5 JP 2013520167A5 JP 2012553903 A JP2012553903 A JP 2012553903A JP 2012553903 A JP2012553903 A JP 2012553903A JP 2013520167 A5 JP2013520167 A5 JP 2013520167A5
Authority
JP
Japan
Prior art keywords
subject
pharmaceutical composition
immune response
administration
influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012553903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013520167A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/000300 external-priority patent/WO2011102900A1/en
Publication of JP2013520167A publication Critical patent/JP2013520167A/ja
Publication of JP2013520167A5 publication Critical patent/JP2013520167A5/ja
Pending legal-status Critical Current

Links

JP2012553903A 2010-02-18 2011-02-18 万能ウイルス様粒子(vlp)インフルエンザワクチン Pending JP2013520167A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30576810P 2010-02-18 2010-02-18
US30575910P 2010-02-18 2010-02-18
US61/305,759 2010-02-18
US61/305,768 2010-02-18
PCT/US2011/000300 WO2011102900A1 (en) 2010-02-18 2011-02-18 Universal virus-like particle (vlp) influenza vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016131988A Division JP6524555B2 (ja) 2010-02-18 2016-07-01 万能ウイルス様粒子(vlp)インフルエンザワクチン

Publications (2)

Publication Number Publication Date
JP2013520167A JP2013520167A (ja) 2013-06-06
JP2013520167A5 true JP2013520167A5 (enExample) 2014-04-03

Family

ID=44483229

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012553903A Pending JP2013520167A (ja) 2010-02-18 2011-02-18 万能ウイルス様粒子(vlp)インフルエンザワクチン
JP2016131988A Expired - Fee Related JP6524555B2 (ja) 2010-02-18 2016-07-01 万能ウイルス様粒子(vlp)インフルエンザワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016131988A Expired - Fee Related JP6524555B2 (ja) 2010-02-18 2016-07-01 万能ウイルス様粒子(vlp)インフルエンザワクチン

Country Status (6)

Country Link
US (4) US9352031B2 (enExample)
EP (1) EP2536428B1 (enExample)
JP (2) JP2013520167A (enExample)
CN (1) CN102858368B (enExample)
CA (1) CA2789945A1 (enExample)
WO (1) WO2011102900A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
PT2610345E (pt) 2007-11-27 2016-01-11 Medicago Inc Partículas semelhantes ao vírus (vlps) da gripe recombinantes produzidas em plantas transgénicas que expressam hemaglutinina
WO2011102900A1 (en) 2010-02-18 2011-08-25 Technovax, Inc. Universal virus-like particle (vlp) influenza vaccines
WO2012024283A2 (en) * 2010-08-16 2012-02-23 The Wistar Institute Of Anatomy And Biology Universal influenza a vaccines
US9441019B2 (en) 2011-09-23 2016-09-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Influenza hemagglutinin protein-based vaccines
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
CN116218900A (zh) * 2011-09-30 2023-06-06 麦迪卡格公司 增加植物中病毒样颗粒的产率
WO2013059403A1 (en) * 2011-10-19 2013-04-25 Immunotope, Inc. Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of influenza virus infection
BR112014019755B1 (pt) 2012-03-22 2022-02-22 Fraunhofer Usa, Inc Partícula do tipo viral; método de produção das partículas do tipo viral; composição imunogênica e uso das partículas do tipo viral
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
EP2978848B1 (en) 2013-03-28 2020-05-06 Medicago Inc. Influenza virus-like particle production in plants
JP6535675B2 (ja) * 2013-10-02 2019-06-26 メディミューン,エルエルシー 抗a型インフルエンザ抗体の中和及びその使用
CN105792842B (zh) 2013-10-11 2020-06-02 美利坚合众国, 由健康及人类服务部部长代表 埃巴病毒疫苗
WO2015101666A1 (en) 2014-01-03 2015-07-09 Fundación Biofísica Bizkaia VLPs, METHODS FOR THEIR OBTENTION AND APPLICATIONS THEREOF
US10130700B2 (en) 2014-06-20 2018-11-20 The United States of America, as represented by the Secretary, DHHS Polyvalent influenza virus-like particles (VLPS) and use as vaccines
AU2015373928B2 (en) 2014-12-31 2019-10-17 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Novel multivalent nanoparticle-based vaccines
EP3344290A4 (en) * 2015-08-31 2019-02-27 Technovax, Inc. VACCINE BASED ON VIRUS-LIKE PARTICLES OF HUMAN RESPIRATORY SYNZYTIAL VIRUS (HRSV)
JP7183149B2 (ja) 2016-09-02 2022-12-05 ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプリゼンテッド・バイ・ザ・セクレタリー・デパートメント・オブ・ヘルス・アンド・ヒューマン・サービシーズ 安定化されたグループ2インフルエンザヘマグルチニンステム領域三量体およびその使用
MX2019014943A (es) 2018-12-12 2020-08-06 Cambridge Tech Llc Vacuna universal contra la gripe.
CN110272473B (zh) * 2019-07-10 2021-03-02 军事科学院军事医学研究院军事兽医研究所 甲型流感通用型病毒样颗粒及其制备方法和应用
EP4196160A2 (en) * 2020-08-17 2023-06-21 Technovax, Inc. [sars-cov-2]-virus-like particle [vlp] vaccine: compositions, delivery strategies, methods and uses
CA3196157A1 (en) * 2020-09-21 2022-03-24 University Of Georgia Research Foundation, Inc. Piv5-based covid-19 vaccine
CN112342149A (zh) * 2020-11-12 2021-02-09 新疆畜牧科学院兽医研究所(新疆畜牧科学院动物临床医学研究中心) 一种禽流感病毒样颗粒组装表达系统及其应用
WO2023126982A1 (en) * 2021-12-31 2023-07-06 Mynvax Private Limited Polypeptide fragments, immunogenic composition against influenza virus, and implementations thereof
CN120053630B (zh) * 2025-04-28 2025-07-18 中国医学科学院医学生物学研究所 一种广谱流感疫苗的抗原表位肽组合及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0111830B8 (pt) * 2000-06-23 2021-05-25 American Cyanamid Co método de produção de partículas semelhantes ao vírus da influenza (vlps), vlps da influenza, vlps quiméricas, composições imunogênica e farmacêutica, e, usos de vlps da influenza e de vlps quiméricas
US8592197B2 (en) * 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
US8080255B2 (en) 2003-07-11 2011-12-20 Novavax Inc. Functional influenza virus like particles (VLPs)
US20060051859A1 (en) * 2004-09-09 2006-03-09 Yan Fu Long acting human interferon analogs
BRPI0613625A2 (pt) * 2005-07-19 2011-01-18 Dow Global Technologies Inc vacinas da gripe recombinantes
TWI488968B (zh) * 2005-10-18 2015-06-21 Novavax Inc 功能性流行性感冒類病毒顆粒(VLPs)
WO2007130330A2 (en) * 2006-05-01 2007-11-15 Technovax, Inc. Polyvalent influenza virus-like particle (vlp) compositions
WO2007130327A2 (en) * 2006-05-01 2007-11-15 Technovax, Inc. Influenza virus-like particle (vlp) compositions
EP2044224A4 (en) * 2006-07-27 2011-04-13 Ligocyte Pharmaceuticals Inc CHIMERIC VIRUS TYPE PARTICLES
EP2089515A4 (en) * 2006-11-16 2011-02-23 Novavax Inc VIRUSUAL PARTICLES OF RESPIRATORY SYNZYTIAL VIRUS
US8883479B2 (en) * 2008-11-25 2014-11-11 Baxter Healthcare Sa Method for production of pH stable enveloped viruses
CA2787099A1 (en) * 2009-03-30 2010-10-14 Anice C. Lowen Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
WO2011102900A1 (en) * 2010-02-18 2011-08-25 Technovax, Inc. Universal virus-like particle (vlp) influenza vaccines
KR102072582B1 (ko) * 2012-12-31 2020-02-03 엘지전자 주식회사 듀얼 디스플레이 방법 및 장치

Similar Documents

Publication Publication Date Title
JP2013520167A5 (enExample)
JP2013014622A5 (enExample)
WO2011103453A3 (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease
JP2017509667A5 (enExample)
JP2015525757A5 (enExample)
JP2011105738A5 (enExample)
JP2012143233A5 (enExample)
JP2012107057A5 (enExample)
JP2019516735A5 (enExample)
JP2015501646A5 (enExample)
JP2015518492A5 (enExample)
JP2016500312A5 (enExample)
JP2016540026A5 (enExample)
JP2015511646A5 (enExample)
JP2012516348A5 (enExample)
JP2014507563A5 (enExample)
JP2014531010A5 (enExample)
JP2014529579A5 (enExample)
JP2015030781A5 (enExample)
CL2013002325A1 (es) Compuestos derivados de 4-amino-2-butenamidas, inhibidores de catepsina c; composicion farmaceutica que los comprende; procedimiento de preparacion de la composicion farmaceutica; uso del compuesto en el tratamiento de enfermedad pulmonar obstructiva cronica.
JP2017014205A5 (enExample)
WO2016020408A3 (en) Compounds for preventing ototoxicity
JP2017516883A5 (enExample)
HK1179177A (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease
CN302299574S (zh) 硬盘支架